To analyze the clinical research of partial splenic artery embolization in the treatment of cirrhosis with hypersplenism

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200056555

Enrollment

Unknown

Registered

2022-02-07

Start date

2022-02-06

Completion date

Unknown

Last updated

2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Partial splenic embolism

Interventions

Case series:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing partial splenic artery embolization

Exclusion criteria

Exclusion criteria: 1. No complete case information; 2. Patients who cannot be distinguished from tumor thrombus.

Design outcomes

Primary

Measure	Time frame
Computed tomography;Magnetic resonance imaging;Liver function;Blood coagulation function;Blood routine;	—

Countries

China

Contacts

Public ContactSong Yuhu

Tongji Medical College of Huazhong University of Science and Technology

yuhusong@163.com+86 15007187581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026